Nanopore Sequencing

Description: Nanopore sequencing is an innovative method for sequencing DNA that involves passing a DNA molecule through a nanopore, an extremely small structure that allows for the detection of changes in electrical current. This process is based on the interaction between the DNA molecule and the nanopore, where each base of the DNA causes a variation in the current that can be measured. Unlike traditional sequencing techniques, which require DNA amplification and are slower and more expensive, nanopore sequencing allows for the direct reading of long DNA strands in real-time. This not only speeds up the sequencing process but also significantly reduces associated costs. The ability to read DNA sequences continuously and in real-time opens new possibilities in genetic research, personalized medicine, and disease diagnosis. Additionally, nanopore sequencing technology is portable, allowing for its use in diverse environments including field settings where access to sophisticated laboratories is limited. In summary, nanopore sequencing represents a significant advancement in biotechnology, facilitating faster and more economical access to genetic information.

History: Nanopore sequencing was developed in the early 2000s, with key contributions from researchers like David Deamer and his team at the University of California, Santa Cruz. In 2005, Oxford Nanopore Technologies was founded with the goal of commercializing this technology. In 2012, they launched the first portable sequencing device, the MinION, which allowed researchers to perform real-time sequencing in various environments.

Uses: Nanopore sequencing is used in various applications, including genomic research, disease diagnosis, microbiology, and environmental biology. Its ability to sequence DNA in real-time makes it ideal for field studies and real-time pathogen monitoring.

Examples: A practical example of nanopore sequencing is its use in identifying strains of viruses during epidemic outbreaks, such as the Ebola virus and SARS-CoV-2, where rapid genetic characterization is needed for disease control.

  • Rating:
  • 3
  • (3)

Deja tu comentario

Your email address will not be published. Required fields are marked *

PATROCINADORES

Glosarix on your device

Install
×
Enable Notifications Ok No